Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Here’s Why Traders Are Buzzing about These Five Stocks on Monday

Page 1 of 2

It’s M&A Monday as Pfizer Inc. (NYSE:PFE), Anacor Pharmaceuticals Inc (NASDAQ:ANAC), Range Resources Corp. (NYSE:RRC), and Memorial Resource Development Corp (NASDAQ:MRD) each participated in meaningful M&A events that caused each stock to trend. In addition, big news concerning Apple Inc. (NASDAQ:AAPLhas also sent shares of the tech giant up today. Let’s take a closer look and see how the smart money is positioned in each stock.

Given that Insider Monkey has done a lot of research into what the smart money likes and doesn’t like, let’s also analyze relevant hedge fund sentiment toward the stocks. At Insider Monkey, we track around 730 hedge funds and institutional investors. Through extensive backtests, we have determined that imitating some of the stocks that these investors are collectively bullish on, can help retail investors generate double digits of alpha per year. The key is to focus on the small-cap picks of these funds, which are usually less followed by the broader market and allow for larger price inefficiencies (see the details here).

Apple Gets Some Love From Berkshire

Although Carl Icahn sold out of Apple Inc. (NASDAQ:AAPL) due to concerns that the Chinese government might make it difficult for the tech giant to do business in the country, billionaire Warren Buffett  apparently isn’t as concerned. According to its recent 13F filing with the SEC, Berkshire Hathaway acquired 9.8 million shares in Apple Inc. (NASDAQ:AAPL) during the first quarter. That gives Buffett’s company a stake of around $1 billion. The purchase of Apple is notable because Buffett has long said that he doesn’t invest in new tech companies. Berkshire’s bet in Apple is bullish for the stock because it shows that the world’s greatest investor thinks that the company has a sustainable moat and is undervalued. Shares of Apple opened over 2% in the green today. Apple has also recently tried to smooth things over with the Chinese government by agreeing to invest $1 billion in leading Chinese ride sharing app, Didi Chuxing. Investors hope that Apple’s willingness to invest in Chinese startups will help the company remain in the government’s good graces. That would help Apple maintain its very profitable China business. In our database, Berkshire trails  Ken Fisher’s Fisher Asset Management, which owns 11.32 million shares of Apple as of the end of March.

Follow Apple Inc (NASDAQ:AAPL)
Trade (NASDAQ:AAPL) Now!

Pfizer Buys Anacor

Pfizer Inc. (NYSE:PFE) and Anacor Pharmaceuticals Inc (NASDAQ:ANAC) are trending today after Pfizer agreed to buy Anacor Pharmaceuticals Inc (NASDAQ:ANAC) for $4.45 billion or $99.25 per share in cash. Pfizer Inc. (NYSE:PFE) has fallen 0.6% on the news while Anacor shares have surged 54% in pre-market trading. Although it is a cash flow machine, Pfizer has several drugs that face the patent cliff in the coming years, and the giant needs new drugs to sustain its earnings. Although it has a promising pipeline, the company has used M&A to supplement its growth before, and the Anacor acquisition will certainly help. Anacor’s main drug, crisaborole, which is currently under FDA review for the treatment of mild and moderate eczema, could potentially realize peak sales of $2 billion a year. Among the funds we track, Ken Fisher’s Fisher Asset Management is a major shareholder of Pfizer while Mark Kingdon’s Kingdon Capital owns a substantial position in Anacor Pharmaceuticals.

Follow Pfizer Inc (NYSE:PFE)
Trade (NYSE:PFE) Now!

Follow Anacor Pharmaceuticals Inc. (NASDAQ:ANAC)
Trade (NASDAQ:ANAC) Now!

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!